SCHEMBL532874

SCHEMBL532874

Cc1cc(C)c(N2CCCC2)c(C)c1NC(=O)c1c(Cl)cccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.45
NPSR1 Q6W5P4 7/20 0.44
CYP2C19 P33261 2/20 0.44
MEN1 O00255 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
RAB9A P51151 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 5/20 0.41
ATM Q13315 5/20 0.41
TSHR P16473 3/20 0.41
HPGD P15428 2/20 0.41
MAPK1 P28482 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TP53 P04637 2/20 0.41
THRB P10828 1/20 0.41
POLB P06746 2/20 0.41
KDM4E B2RXH2 1/20 0.40
ALOX12 P18054 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8322542 0.88 HTT (0.39) KMT2ANPSR1CYP2C19MEN1CYP3A4
SCHEMBL533027 0.87 RAB9A (0.56) KMT2ANPSR1CYP2C19MEN1CYP3A4
SCHEMBL532950 0.87 KMT2A (0.56) KMT2ANPSR1CYP2C19MEN1CYP3A4
SCHEMBL533977 0.83 GAA (0.57) KMT2ANPSR1CYP2C19CYP3A4RAB9A
SCHEMBL532034 0.83 NPC1 (0.57) KMT2AMEN1RAB9AALDH1A1HPGD
SCHEMBL532972 0.82 POLB (0.44) KMT2ANPSR1CYP2C19MEN1CYP3A4
SCHEMBL532983 0.81 MAPT (0.46) KMT2ANPSR1CYP2C19MEN1CYP3A4
SCHEMBL532849 0.81 SMN1; SMN2 (0.49) KMT2AMEN1RAB9AALDH1A1HPGD
SCHEMBL533054 0.81 MAPT (0.45) KMT2AMEN1RAB9AALDH1A1TSHR
SCHEMBL532941 0.81 MAPT (0.51) KMT2AMEN1RAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed